Alnylam Pharmaceuticals shares owned by Goodman & Company, Investment Counsel
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Goodman & Company, Investment Counsel
from 13F filings
Historical chart of Goodman & Company, Investment Counsel investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Goodman & Company, Investment Counsel consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Goodman & Company, Investment Counsel
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $97k | 545 | 177.10 |
| 2023-06-30 | $104k | 545 | 189.94 |
| 2023-03-31 | $4.6M | 23k | 200.32 |
| 2022-12-31 | $93M | 391k | 237.65 |
| 2022-09-30 | $78M | 387k | 200.16 |
| 2022-06-30 | $79k | 545 | 144.95 |
| 2022-03-31 | $88k | 545 | 161.47 |
| 2020-03-31 | $2.3M | 21k | 109.57 |
More positions owned by Goodman & Company, Investment Counsel
View all positions for Goodman & Company, Investment Counsel